To that end, we used the METABRIC BC dataset, in which both the transcriptome (Curtis et al., 2012; Rueda, 2019) and the p53 mutation status (Pereira et al., 2016; Silwal‐Pandit et al., 2014) are described for a large number of samples. This evidence concerns the gene TP53 and breast cancer.